Clinical Trial Update: Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin. [Phase 2]

View source ↗

Summary

This is a phase 2 trial evaluating the combination of platinum-doublet chemotherapy with nivolumab for gastroenteropancreatic neuroendocrine tumors and neuroend…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteropancreatic Neuroendocrine Tumor
• Neuroendocrine Neoplasm
• Neuroendocrine Tumor

Drugs mentioned

• Opdivo (nivolumab) (nivolumab)
• Platinum-doublet chemotherapy

Snippet

Sponsor: Grupo Espanol de Tumores Neuroendocrinos | Conditions: Neuroendocrine Tumors, Neuroendocrine Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2025-01-13